Advertisement
Advertisement

Big Money Dumps InMode

By:
Lucas Downey
Updated: Jan 11, 2022, 12:30 UTC

InMode Ltd. (INMD) stock has fallen, losing -23.3% this year. The specialty medical device maker pulled back with the weakness in growth stocks. But another likely reason is Big Money dropping the stock.

Big Money Dumps InMode

In this article:

So, what’s Big Money? Said simply, that’s when a stock goes down in price alongside chunky volumes. It’s indicative of institutions selling the shares.

Smart money managers are always looking for the next hot stock. And InMode has many fundamental qualities that are attractive. But sometimes when values decline, money managers look to sell or may be forced to liquidate.

This downward movement creates uncertainty for the stock going forward. And as I’ll show you, the Big Money has been exiting the shares recently.

You see, fund managers are always looking to bet on the next outlier stocks…the best in class. They spend countless hours sizing up companies, reading reports, speaking to analysts…you name it. When they find a company firing on all cylinders, they pounce in a big way. But Big Money sells too, especially when the situation changes.

That’s why I’ve learned how critical it is to gauge Big Money demand for shares. To show you what I mean, have a look at all the Big Money signals INMD has made the last year.

We’ve recently seen Big Money selling activity. Each red bar signals big trading volumes as the stock price dipped:

undefined

Source: www.mapsignals.com

In the last three months the stock attracted 4 Big Money sell signals. Generally speaking, recent red bars could mean more uncertainty is ahead.

Now, let’s check out technical action grabbing my attention:

Vast underperformance is an obvious red flag for leading stocks.

Next, it’s a good idea to check under the hood. Meaning, I want to understand the fundamental story too. As you can see, InMode has been growing sales and earnings at a double-digit rate. Take a look:

  • 3-year sales growth rate (+58.4%)
  • 3-year earnings growth rate (+119.7%)

Source: FactSet

Marrying great fundamentals with technically superior stocks is a winning recipe over the long-term. But when there is disagreement between the two, it could mean the situation has changed. Or it could be a huge long-term value play on a great stock.

In fact, INMD has been a top-rated stock at my research firm, MAPsignals. That means the stock has had buy pressure, strong technicals, and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis. Usually when selling dries up, great stocks rally again.

INMD has had a lot of qualities that attracted Big Money. Since it began trading in 2019, it’s made the MAPsignals top list 20 times, with its first appearance on 12/22/2020…and gaining +128.01% since.

Despite the recent decline, the fundamental story is strong. The blue bars below show the times that InMode was a top pick since 2019:

undefined

Source: www.mapsignals.com

It’s been a top stock in the health care sector according to the MAPsignals process. I wouldn’t be surprised if INMD reappears on this list in the years to come. Let’s tie this all together.

The Bottom Line

The InMode decline makes the stock look oversold. Big Money selling in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be a huge value play long-term and still worth a spot in a growth-oriented portfolio.

Disclosure: the author holds long positions in INMD in personal and managed accounts at the time of publication.

Learn more about the MAPsignals process here.

Disclaimer

https://mapsignals.com/contact/

 

About the Author

Lucas Downeycontributor

Lucas is a well-versed equity investor and educator. He currently is co-founder of research and analytics firm, MAPsignals.com, which focuses on finding outlier stocks by following the Big Money.

Did you find this article useful?

Advertisement